fda warning letters glp-1 september 2025 news NCL Issues a Second Alert to Heed Warnings About Unregulated Versions of GLP -1 Weight Loss Drugs September 8, 2025: FDA launches

While it wont cause a false positive for illegal drugs, it will help your doctor understand why your blood sugar, A1c, or cholesterol levels have improved and ensure they interpret your kidney and liver function markers with the correct context

If gastrointestinal side effects are intolerable despite optimal management, discontinuation may be appropriate, and your healthcare team can discuss alternative treatment options

21 November 2009

In conclusion, while more long-term data and randomized controlled trials are necessary to establish the definitive renoprotective effects of Tirzepatide, current evidence is promising